- Report
- April 2020
- 110 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- April 2023
- 240 Pages
Global
From €3137EUR$3,250USD£2,691GBP
- Report
- July 2022
- 196 Pages
Global
From €7239EUR$7,500USD£6,210GBP
- Report
- February 2022
- 269 Pages
Global
From €9169EUR$9,500USD£7,866GBP
- Report
- January 2022
- 200 Pages
Global
From €7239EUR$7,500USD£6,210GBP
- Report
- January 2022
- 120 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2024
- 157 Pages
Global
From €3651EUR$3,783USD£3,132GBP
€4295EUR$4,450USD£3,684GBP
- Report
- January 2024
- 95 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- August 2023
- 89 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- March 2023
- 132 Pages
Global
From €917EUR$950USD£787GBP
- Report
- November 2022
- 132 Pages
Global
From €917EUR$950USD£787GBP
- Report
- August 2022
- 385 Pages
Global
From €5568EUR$5,769USD£4,776GBP
- Report
- February 2024
- 180 Pages
Global
From €5308EUR$5,499USD£4,553GBP
The emollient market within the context of dermatological drugs is a segment of the pharmaceutical industry that focuses on the development and production of products that are used to treat skin conditions. These products are designed to soothe, soften, and protect the skin from further damage. They are often used to treat dry skin, eczema, psoriasis, and other skin conditions. Emollients are available in a variety of forms, including creams, ointments, lotions, and sprays.
Emollients are often used in combination with other treatments, such as topical steroids, to provide the best results. They are also used to help reduce the risk of skin irritation and infection.
Some of the major companies in the emollient market include GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, and Merck. These companies produce a wide range of products, including creams, ointments, lotions, and sprays. Show Less Read more
